Join us to learn more about the latest research at the Johns Hopkins Alzheimer’s Disease Research Center. Dr. Marilyn Albert discusses using biomarkers, including those derived from cerebrospinal fluid, magnetic resonance, positron emission tomography, and genetics, to predict which individuals with normal cognition are likely to progress to mild cognitive impairment and dementia. She is also engaged in examining lifestyle factors that may reduce the risk of cognitive decline in older persons. The ultimate goal of this research is to improve early diagnosis and the design of clinical trials, so that early and effective treatments can be implemented in patients.

Dr. Marilyn Albert is a Professor of Neurology, Neuroscience, Pathology, and Psychiatry and Behavioral Sciences. She is the Director of the Division of Cognitive Neuroscience in the Department of Neurology and Director of the Johns Hopkins Alzheimer's Disease Research Center. Dr. Albert focuses on the cognitive and brain changes associated with aging and Alzheimer’s disease (AD). Her work has delineated the cognitive changes associated with aging and early AD, along with potential methods of early identification of AD. She has also identified lifestyle factors that promote the maintenance of mental abilities with advancing age.

Dr. Albert received her doctorate in physiological psychology from McGill University in Montreal and completed a fellowship in neuropsychology at Boston University School of Medicine. She served on the faculty of the Harvard Medical School for over 22 years before coming to Johns Hopkins.

Sponsored by the Johns Hopkins Medicine Department of Neurology and Brain Sciences and the Johns Hopkins University School of Medicine Office of Alumni Relations.